MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $644,676 (100.0% shares, 0.0% debt)

Holdings (33)

CGEM Cullinan Oncology, Inc. 26.8%

Value ($000) $172,621 Shares 7,648,268 Est. Cost $40.60 Unrealized -34.1%

— iTeos Therapeutics, Inc. 8.8%

Value ($000) $56,891 Shares 2,107,092 Est. Cost $24.67 Unrealized —

— Repare Therapeutics, Inc. 6.7%

Value ($000) $43,030 Shares 1,639,849 Est. Cost $31.02 Unrealized —

HOWL Werewolf Therapeutics, Inc. 6.4%

Value ($000) $40,978 Shares 2,388,011 Est. Cost $13.70 Unrealized +24.6%

— MEI Pharma, Inc. 5.3%

Value ($000) $34,484 Shares 12,494,118 Est. Cost $3.05 Unrealized —

— TCR2 Therapeutics, Inc. 4.4%

Value ($000) $28,687 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— Harpoon Therapeutics, Inc. 3.9%

Value ($000) $25,254 Shares 3,196,707 Est. Cost $14.79 Unrealized —

— Oncorus, Inc. 3.4%

Value ($000) $22,201 Shares 2,377,031 Est. Cost $32.33 Unrealized —

NTLA Intellia Therapeutics, Inc. 3.4%

Value ($000) $21,815 Shares 162,620 Est. Cost $151.40 Unrealized 0.0%

— Merus N.V. 3.2%

Value ($000) $20,723 Shares 941,948 Est. Cost $17.60 Unrealized —

— Epizyme, Inc. 3.2%

Value ($000) $20,341 Shares 3,972,830 Est. Cost $15.19 Unrealized —

— Turning Point Therapeutics, Inc. 2.8%

Value ($000) $18,026 Shares 271,350 Est. Cost $44.66 Unrealized —

— YmAbs Therapeutics, Inc. 2.0%

Value ($000) $12,928 Shares 452,970 Est. Cost $30.56 Unrealized —

— G1 Therapeutics, Inc. 1.8%

Value ($000) $11,548 Shares 860,502 Est. Cost $25.71 Unrealized —

BCRX Biocryst Pharmaceuticals Inc. 1.6%

Value ($000) $10,128 Shares 704,767 Est. Cost $15.77 Unrealized 0.0%

ADCT ADC Therapeutics, Inc. 1.5%

Value ($000) $9,357 Shares 344,519 Est. Cost $33.59 Unrealized -23.8%

CYTK Cytokinetics Inc. 1.4%

Value ($000) $8,838 Shares 247,291 Est. Cost $29.44 Unrealized 0.0%

— Verastem, Inc. 1.3%

Value ($000) $8,701 Shares 2,824,857 Est. Cost $3.08 Unrealized —

GERN Geron Corporation 1.2%

Value ($000) $7,854 Shares 5,732,770 Est. Cost $1.33 Unrealized 0.0%

TVTX Travere Therapeutics Inc. 1.2%

Value ($000) $7,433 Shares 306,515 Est. Cost $18.37 Unrealized 0.0%

NEO Neogenomics Inc. 1.1%

Value ($000) $7,212 Shares 149,504 Est. Cost $46.29 Unrealized 0.0%

CRNX Crinetics Pharmaceuticals Inc. 1.0%

Value ($000) $6,281 Shares 298,392 Est. Cost $20.92 Unrealized 0.0%

MIRM Mirum Pharmaceuticals Inc. 1.0%

Value ($000) $6,146 Shares 308,532 Est. Cost $16.26 Unrealized 0.0%

HRMY Harmony Biosciences Hldgs Inc. 0.9%

Value ($000) $5,813 Shares 151,650 Est. Cost $32.20 Unrealized 0.0%

— ESSA Pharma, Inc. 0.8%

Value ($000) $5,466 Shares 683,287 Est. Cost $8.00 Unrealized —

FOLD Amicus Therapeutics Inc. 0.8%

Value ($000) $5,220 Shares 546,558 Est. Cost $10.23 Unrealized 0.0%

— AVROBIO, Inc. 0.7%

Value ($000) $4,809 Shares 861,858 Est. Cost $5.58 Unrealized —

— Lucira Health Inc. 0.7%

Value ($000) $4,394 Shares 578,114 Est. Cost $7.60 Unrealized —

RVMD Revolution Medicines, Inc. 0.6%

Value ($000) $4,127 Shares 150,000 Est. Cost $29.11 Unrealized 0.0%

— Avadel Pharmaceuticals Plc 0.6%

Value ($000) $3,920 Shares 400,000 Est. Cost $9.80 Unrealized —

— Inozyme Pharma Inc. 0.6%

Value ($000) $3,717 Shares 320,724 Est. Cost $11.59 Unrealized —

AXSM Axsome Therapeutics Inc. 0.6%

Value ($000) $3,631 Shares 110,155 Est. Cost $38.97 Unrealized 0.0%

BDTX Black Diamond Therapeutics, Inc. 0.3%

Value ($000) $2,102 Shares 248,506 Est. Cost $9.87 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	7,648,268	$172,621	26.8%	$40.60	-34.1%	Common	230031106
—	iTeos Therapeutics, Inc.	2,107,092	$56,891	8.8%	$24.67	—	Common	46565G104
—	Repare Therapeutics, Inc.	1,639,849	$43,030	6.7%	$31.02	—	Common	760273102
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$40,978	6.4%	$13.70	+24.6%	Common	95075A107
—	MEI Pharma, Inc.	12,494,118	$34,484	5.3%	$3.05	—	Common	552798202
—	TCR2 Therapeutics, Inc.	3,370,982	$28,687	4.4%	$14.28	—	Common	87808K106
—	Harpoon Therapeutics, Inc.	3,196,707	$25,254	3.9%	$14.79	—	Common	41358P106
—	Oncorus, Inc.	2,377,031	$22,201	3.4%	$32.33	—	Common	68236R103
NTLA	Intellia Therapeutics, Inc.	162,620	$21,815	3.4%	$151.40	0.0%	Common	45826J105
—	Merus N.V.	941,948	$20,723	3.2%	$17.60	—	Common	N5749R100
—	Epizyme, Inc.	3,972,830	$20,341	3.2%	$15.19	—	Common	29428V104
—	Turning Point Therapeutics, Inc.	271,350	$18,026	2.8%	$44.66	—	Common	90041T108
—	YmAbs Therapeutics, Inc.	452,970	$12,928	2.0%	$30.56	—	Common	984241109
—	G1 Therapeutics, Inc.	860,502	$11,548	1.8%	$25.71	—	Common	3621LQ109
BCRX	Biocryst Pharmaceuticals Inc.	704,767	$10,128	1.6%	$15.77	0.0%	Common	09058V103
ADCT	ADC Therapeutics, Inc.	344,519	$9,357	1.5%	$33.59	-23.8%	Common	H0036K147
CYTK	Cytokinetics Inc.	247,291	$8,838	1.4%	$29.44	0.0%	Common	23282W605
—	Verastem, Inc.	2,824,857	$8,701	1.3%	$3.08	—	Common	92337C104
GERN	Geron Corporation	5,732,770	$7,854	1.2%	$1.33	0.0%	Common	374163103
TVTX	Travere Therapeutics Inc.	306,515	$7,433	1.2%	$18.37	0.0%	Common	89422G107
NEO	Neogenomics Inc.	149,504	$7,212	1.1%	$46.29	0.0%	Common	64049M209
CRNX	Crinetics Pharmaceuticals Inc.	298,392	$6,281	1.0%	$20.92	0.0%	Common	22663K107
MIRM	Mirum Pharmaceuticals Inc.	308,532	$6,146	1.0%	$16.26	0.0%	Common	604749101
HRMY	Harmony Biosciences Hldgs Inc.	151,650	$5,813	0.9%	$32.20	0.0%	Common	413197104
—	ESSA Pharma, Inc.	683,287	$5,466	0.8%	$8.00	—	Common	29668H708
FOLD	Amicus Therapeutics Inc.	546,558	$5,220	0.8%	$10.23	0.0%	Common	03152W109
—	AVROBIO, Inc.	861,858	$4,809	0.7%	$5.58	—	Common	05455M100
—	Lucira Health Inc.	578,114	$4,394	0.7%	$7.60	—	Common	54948U105
RVMD	Revolution Medicines, Inc.	150,000	$4,127	0.6%	$29.11	0.0%	Common	76155X100
—	Avadel Pharmaceuticals Plc	400,000	$3,920	0.6%	$9.80	—	Common	05337M104
—	Inozyme Pharma Inc.	320,724	$3,717	0.6%	$11.59	—	Common	45790W108
AXSM	Axsome Therapeutics Inc.	110,155	$3,631	0.6%	$38.97	0.0%	Common	05464T104
BDTX	Black Diamond Therapeutics, Inc.	248,506	$2,102	0.3%	$9.87	0.0%	Common	09203E105